Shingles and RSV vaccines with AS01 adjuvant reduce dementia risk
Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of developing dementia within 18 months compared to flu vaccine recipients. The protective…